๐ฐ Multiple Sclerosis Functional Composite News
Multiple Sclerosis Functional Composite News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Multiple Sclerosis Functional Composite. Real-time updates on events, politics, business and more.
February 29, 2024
Long-term CNM-Au8 treatment demonstrated significant and clinically meaningful improvement of vision as measured by low contrast letter acuity (LC...
September 12, 2023
Ad Scientiam Launches International Study to Assess Disability Progression ...
September 12, 2023
Ad Scientiam Launches International Study to Assess Disability Progression in Multiple Sclerosis With MSCopilot PARIS, FRANCE / ACCESSWIRE / September 12, 2023 / Ad Scientiam, a global leader in...
April 26, 2023
Supplements with tauroursodeoxycholic acid (TUDCA) were generally well tolerated among people with progressive forms of MS in a small trial.ย
March 1, 2023
The upcoming global Phase 3 clinical trial will test CNM-Au8's effect on MS disease progression that occurs independently of relapse activity.
April 12, 2022
A significant association between Mediterranean diet score and MS-related disability was found, which suggests the potential of a neuroprotective mechanism.
April 1, 2022
A significant association between Mediterranean diet score and MS-related disability was found, which suggests the potential of a neuroprotective mechanism.
October 5, 2021
/PRNewswire/ - Innodem Neurosciences announced today that it has signed a multi-year partnership agreement with Novartis Pharmaceuticals Canada Inc. (Novartis)...
October 5, 2021
/PRNewswire/ - Innodem Neurosciences announced today that it has signed a multi-year partnership agreement with Novartis Pharmaceuticals Canada Inc. (Novartis)...
May 12, 2021
Clene Reports First Quarter 2021 Operating and Financial Highlights May 11, 2021 07:00 ET | Source: Clene Inc. Clene Inc. Salt Lake City, UNITED STATES Interim Phase 2 data indicate that CNM-Au8 has a homeostatic effect on brain bioenergetics and support its potential to drive meaningful neurological functional improvements in MS patients Awarded Michael J. Fox Foundation (MJFF) grant to accelerate development of CNM-Au8 as a treatment for Parkinson๏ฟฝ...